drugset / Trial / NCT03942029
A Drug Interaction Study of LY3154207 in Healthy Participants
RandomizedSequentialDouble-blindBasic science
Summary
The main purpose of this study is to learn more about the safety and side effects of LY3154207 and fluconazole (anti-fungal medication), when taken together by healthy participants. The study will last from nine to 11 weeks for each participant.
Timeline
- Start
- 2019-06-21
- Primary completion
- 2019-12-28
- Completion
- 2019-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluconazole | Small molecule | — | Oral |
| Subject | Mevidalen | Small molecule | — | Oral |
Indications
No indication recorded.